107 related articles for article (PubMed ID: 26278417)
1. Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?
Yuksel UM; Turker I; Dilek G; Dogan L; Gulcelik MA; Oksuzoglu B
Oncol Res Treat; 2015; 38(9):431-4. PubMed ID: 26278417
[TBL] [Abstract][Full Text] [Related]
2. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.
Yuksel UM; Dilek G; Dogan L; Gulcelik MA; Berberoglu U
Tumori; 2015; 101(2):194-8. PubMed ID: 25791533
[TBL] [Abstract][Full Text] [Related]
3. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
4. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.
Chang CC; Tai CJ; Su TC; Shen KH; Lin SH; Yeh CM; Yeh KT; Lin YM; Jiang MC
Ann Diagn Pathol; 2012 Oct; 16(5):362-8. PubMed ID: 22476051
[TBL] [Abstract][Full Text] [Related]
6. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
[TBL] [Abstract][Full Text] [Related]
7. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.
Tai CJ; Su TC; Jiang MC; Chen HC; Shen SC; Lee WR; Liao CF; Chen YC; Lin SH; Li LT; Shen KH; Yeh CM; Yeh KT; Lee CH; Shih HY; Chang CC
J Transl Med; 2013 Jan; 11():29. PubMed ID: 23369209
[TBL] [Abstract][Full Text] [Related]
8. The role of CSE1L expression in cervical lymph node metastasis of larynx tumors.
Tunccan T; Duzer S; Dilek G; Yuksel UM; Cetiner H; Kılıc C; Ant A; Duran AB
Braz J Otorhinolaryngol; 2021; 87(1):42-46. PubMed ID: 31383592
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
[TBL] [Abstract][Full Text] [Related]
10. Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.
Tai CJ; Liao CF; Su TC; Shen KH; Chang CC; Lin SH; Yeh CM; Shen SC; Lee WR; Chiou JF; Lin CH; Chen YC; Shih HY; Yeh KT; Jiang MC
Int J Biol Markers; 2012 Oct; 27(3):e280-4. PubMed ID: 22653741
[TBL] [Abstract][Full Text] [Related]
11. CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Cheng DD; Lin HC; Li SJ; Yao M; Yang QC; Fan CY
Sci Rep; 2017 Apr; 7():46238. PubMed ID: 28387323
[TBL] [Abstract][Full Text] [Related]
12. Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer.
Stella Tsai CS; Chen HC; Tung JN; Tsou SS; Tsao TY; Liao CF; Chen YC; Yeh CY; Yeh KT; Jiang MC
Am J Pathol; 2010 Apr; 176(4):1619-28. PubMed ID: 20150437
[TBL] [Abstract][Full Text] [Related]
13. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
Jiang MC
Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
[TBL] [Abstract][Full Text] [Related]
14. Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer.
Suen D; Chow LW
Biomed Pharmacother; 2006 Jul; 60(6):293-7. PubMed ID: 16828252
[TBL] [Abstract][Full Text] [Related]
15. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.
Tai CJ; Hsu CH; Shen SC; Lee WR; Jiang MC
J Exp Clin Cancer Res; 2010 Aug; 29(1):110. PubMed ID: 20701792
[TBL] [Abstract][Full Text] [Related]
16. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
17. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
Tanaka T; Ohkubo S; Tatsuno I; Prives C
Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
[TBL] [Abstract][Full Text] [Related]
18. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
19. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
Liao CF; Lin SH; Chen HC; Tai CJ; Chang CC; Li LT; Yeh CM; Yeh KT; Chen YC; Hsu TH; Shen SC; Lee WR; Chiou JF; Luo SF; Jiang MC
Mol Med; 2012 Dec; 18(1):1269-80. PubMed ID: 22952058
[TBL] [Abstract][Full Text] [Related]
20. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
Liu H; Mao H; Fu X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
